Suppr超能文献

鉴别恶性胸腔积液和特发性胸腔积液:诊断程序的价值

Differentiating between malignant and idiopathic pleural effusions: the value of diagnostic procedures.

作者信息

Alemán C, Sanchez L, Alegre J, Ruiz E, Vázquez A, Soriano T, Sarrapio J, Teixidor J, Andreu J, Felip E, Armadans L, Fernández De Sevilla T

机构信息

Department of Internal Medicine, Hospital Vall d'Hebron, Barcelona 08035, Spain.

出版信息

QJM. 2007 Jun;100(6):351-9. doi: 10.1093/qjmed/hcm032.

Abstract

BACKGROUND

Which diagnostic procedures should be used to differentiate between idiopathic and malignant pleural effusions, is not well established.

AIM

To identify which parameters allow differentiation between idiopathic and malignant pleural effusions.

DESIGN

Case-note review.

METHODS

Over a 12-year period, we treated 1014 consecutive pleural effusion patients, of whom 346 were diagnosed as having an idiopathic or malignant aetiology. We analysed medical history, chest X-ray, pleural fluid analysis (biochemical, microbiological and cytological), chest CT scan and additional examinations that were used according to clinical findings, and compared them with the eventual diagnosis and outcome.

RESULTS

Eighty-three patients with idiopathic effusions and 263 with malignant effusions were included. Idiopathic pleural effusion resolved in 47 patients, improved in 20 and persisted in 16. Biochemical pleural fluid analysis did not predict these outcomes. A history of neoplasm, chest X-ray and CT features, as well as additional examinations according to clinical findings, established a diagnosis or suspicion of malignancy in 256 (97.7%) of the 263 patients who received a diagnosis of malignant effusion. Diagnostic thoracoscopy was helpful in seven patients in whom malignant disease was strongly suspected, despite the absence of other pathological findings.

DISCUSSION

Non-invasive complementary examinations generally allowed accurate differentiation between malignant and idiopathic effusions. Patients with idiopathic pleural effusions generally had favourable outcomes.

摘要

背景

用于区分特发性和恶性胸腔积液的诊断程序尚未明确。

目的

确定哪些参数可用于区分特发性和恶性胸腔积液。

设计

病例记录回顾。

方法

在12年期间,我们连续治疗了1014例胸腔积液患者,其中346例被诊断为特发性或恶性病因。我们分析了病史、胸部X线、胸腔积液分析(生化、微生物学和细胞学)、胸部CT扫描以及根据临床发现进行的其他检查,并将它们与最终诊断和结果进行比较。

结果

纳入83例特发性胸腔积液患者和263例恶性胸腔积液患者。47例特发性胸腔积液患者积液消退,20例改善,16例持续存在。胸腔积液生化分析无法预测这些结果。肿瘤病史、胸部X线和CT特征以及根据临床发现进行的其他检查,在263例被诊断为恶性胸腔积液的患者中有256例(97.7%)确立了恶性肿瘤的诊断或怀疑。诊断性胸腔镜检查对7例尽管没有其他病理发现但高度怀疑恶性疾病的患者有帮助。

讨论

非侵入性补充检查通常可准确区分恶性和特发性胸腔积液。特发性胸腔积液患者通常预后良好。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验